comparemela.com
Home
Live Updates
Mendus AB: Mendus Publishes Preclinical Data Demonstrating S
Mendus AB: Mendus Publishes Preclinical Data Demonstrating S
Mendus AB: Mendus Publishes Preclinical Data Demonstrating Significant Anti-Tumor Synergies of Intratumoral Immune Priming with CTLA-4 Inhibition
Intratumoral injection of allogeneic pro-inflammatory dendritic cells ("ilixadencel") substantially and sustainably enhanced an otherwise ineffective systemic anti CTLA-4 treatment in an established in
Related Keywords
,
Julie Seidel ,
Mario Brkulj ,
Erik Manting ,
Alex Karlsson Parra ,
Drug Administration ,
Valency Communications ,
Chief Scientific Officer ,
Mendus ,
Ublishes ,
Reclinical ,
Data ,
Emonstrating ,
Significant ,
Anti ,
Humor ,
Synergies ,
Ntratumoral ,
Immune ,
Priming ,
Tla ,
Inhibition ,